Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
The nuclear receptors, farnesoid X receptor (FXR) and pregnane X receptor (PXR), are important in maintaining bile acid homeostasis. Deletion of both FXR and PXR in vivo by cross-breeding B6;129-Fxrtm1Gonz (FXR-null) and B6;129-Pxrtm1Glaxo-Wellcome (PXR-null) mice revealed a more severe disruption of bile acid, cholesterol, and lipid homeostasis in B6;129-Fxrtm1Gonz Pxrtm1Glaxo-Wellcome (FXR-PXR double null or FPXR-null) mice fed a 1% cholic acid (CA) diet. Hepatic expression of the constitutive androstane receptor (CAR) and its target genes was induced in FXR- and FPXR-null mice fed the CA diet. To test whether up-regulation of CAR represents a means of protection against bile acid toxicity to compensate for the loss of FXR and PXR, animals were pretreated with CAR activators, phenobarbital or 1,4-bis[2-(3,5-dichlorpyridyloxy)]benzene (TCPOBOP), followed by the CA diet. A role for CAR in protection against bile acid toxicity was confirmed by a marked reduction of serum bile acid and bilirubin concentrations, with an elevation of the expression of the hepatic genes involved in bile acid and/or bilirubin metabolism and excretion (CYP2B, CYP3A, MRP2, MRP3, UGT1A, and glutathione S-transferase alpha), following pretreatment with phenobarbital or TCPOBOP. In summary, the current study demonstrates a critical and combined role of FXR and PXR in maintaining not only bile acid but also cholesterol and lipid homeostasis in vivo. Furthermore, FXR, PXR, and CAR protect against hepatic bile acid toxicity in a complementary manner, suggesting that they serve as redundant but distinct layers of defense to prevent overt hepatic damage by bile acids during cholestasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated BAs can activate the FXR, pregnane X receptor (PXR), and CAR.54,55”
From Constitutive Androstane Receptor Regulates Bile Acid Homeostasis and Metabolism During Liver Regeneration (2026) · cites this paper as [55]
In the citing paper
“Intrahepatic cholestasis can also activate the constitutive androstane receptor (CAR, NR1I3) (Guo et al., 2003; Huang et al., 2005; Ma et al., 2009; Zhang et al., 2004)”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Guo et al., 2003
In the citing paper
“We and others have previously demonstrated that elevated bile acids, as observed in mice lacking circadian homeostasis, activates CAR (Guo et al., 2003; Huang et al., 2005; Ma et al., 2009; Zhang et al., 2004)”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Guo et al., 2003
In the citing paper
“which is well known as a potent tumor promoter that drives non-genotoxic hepatocarcinogenesis (Guo et al., 2003; Huang et al., 2005; Yamamoto et al., 2004; Zhang et al., 2004).”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Guo et al., 2003
Citations
Cites
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Self-citationA regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Self-citationTargeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
Self-citationEndogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379
Self-citationIdentification of a nuclear receptor that is activated by farnesol metabolites
Forman, B. M., Goode, E., Chen, J., Oro, A. E., Bradley, D. J., Perlmann, T., Noonan, D. J., Burka, L. T., McMorris, T., Lamph, W. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90530-8 · Cited by 1,210
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
Xie, W., Radominska-Pandya, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., & Evans, R. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051014398 · Cited by 757
Maglich, J. M., Stoltz, C. M., Goodwin, B., Hawkins-Brown, D., Moore, J. T., & Kliewer, S. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.638 · Cited by 654
Self-citationReciprocal activation of Xenobiotic response genes by nuclear receptors SXR/PXR and CAR
Xie, W., Barwick, J. L., Simon, C. M., Pierce, A. M., Safe, S., Blumberg, B., Guzelian, P. S., & Evans, R. M. (2000) · Genes & Development · doi:10.1101/gad.846800 · Cited by 508
Redundant Pathways for Negative Feedback Regulation of Bile Acid Production
Wang, L., Lee, Y.-K., Bundman, D., Han, Y., Thevananther, S., Kim, C.-S., Chua, S. S., Wei, P., Heyman, R. A., Karin, M., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00187-9 · Cited by 476
Seol, W. (1995) · Molecular Endocrinology · doi:10.1210/me.9.1.72 · Cited by 393
The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis
Lambert, G., Amar, M. J. A., Guo, G., Brewer, H. B., Gonzalez, F. J., & Sinal, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209525200 · Cited by 392
Self-citationInduction of bilirubin clearance by the constitutive androstane receptor (CAR)
Huang, W., Zhang, J., Chua, S. S., Qatanani, M., Han, Y., Granata, R., & Moore, D. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630614100 · Cited by 390
Sugatani, J., Kojima, H., Ueda, A., Kakizaki, S., Yoshinari, K., Gong, Q.-H., Owens, I. S., Negishi, M., & Sueyoshi, T. (2001) · Hepatology · doi:10.1053/jhep.2001.24172 · Cited by 381
Self-citationXie, W., Yeuh, M.-F., Radominska-Pandya, A., Saini, S. P. S., Negishi, Y., Bottroff, B. S., Cabrera, G. Y., Tukey, R. H., & Evans, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438010100 · Cited by 367
Phenobarbital Response Elements of Cytochrome P450 Genes and Nuclear Receptors
Sueyoshi, T., & Negishi, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.123 · Cited by 362
Self-citationIdentification of a Bile Acid-responsive Element in the Human Ileal Bile Acid-binding Protein Gene
Grober, J., Zaghini, I., Fujii, H., Jones, S. A., Kliewer, S. A., Willson, T. M., Ono, T., & Besnard, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29749 · Cited by 353
Self-citationKast, H. R., Nguyen, C. M., Sinal, C. J., Jones, S. A., Laffitte, B. A., Reue, K., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.10.0712 · Cited by 336
Self-citationSchuetz, E. G., Strom, S., Yasuda, K., Lecureur, V., Assem, M., Brimer, C., Lamba, J., Kim, R. B., Ramachandran, V., Komoroski, B. J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106340200 · Cited by 334
Self-citationChen, C. H., & Albers, J. J. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38100-1 · Cited by 297
Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR)
Sonoda, J., Xie, W., Rosenfeld, J. M., Barwick, J. L., Guzelian, P. S., & Evans, R. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212494599 · Cited by 281
Urizar, N. L., Dowhan, D. H., & Moore, D. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007998200 · Cited by 237
Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis
Longo, M., Crosignani, A., Battezzati, P. M., Squarcia Giussani, C., Invernizzi, P., Zuin, M., & Podda, M. (2002) · Gut · doi:10.1136/gut.51.2.265 · Cited by 190
Identification of a Locus for Progressive Familial Intrahepatic Cholestasis PFIC2on Chromosome 2q24
Strautnieks, S. S., Kagalwalla, A. F., Tanner, M. S., Knisely, A. S., Bull, L., Freimer, N., Kocoshis, S. A., Gardiner, R. M., & Thompson, R. J. (1997) · The American Journal of Human Genetics · doi:10.1086/515501 · Cited by 187
Genetic defects in hepatobiliary transport
Elferink, R. P. J. O., & Groen, A. K. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00103-x · Cited by 132
Phenobarbital Effects in Cholestatic Liver Disease
BLOOMER, J. R., & BOYER, J. L. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-3-310 · Cited by 120
Guo, G. L., Choudhuri, S., & Klaassen, C. D. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.206 · Cited by 73
Self-citationStem Cells and Tissue Engineering: Prospects for Regenerating Tissues in Dental Practice
Thesleff, I., & Tümmers, M. (2003) · Medical Principles and Practice · doi:10.1159/000069840 · Cited by 63
The hypercholesterolaemia of obstructive jaundice.
McIntyre, N., Harry, D. S., & Pearson, A. J. G. (1975) · Gut · doi:10.1136/gut.16.5.379 · Cited by 56
Hepatic lipase deficiency decreases the selective uptake of HDL-cholesteryl esters in vivo
Lambert, G., Amar, M. J. A., Martin, P., Fruchart-Najib, J., Föger, B., Shamburek, R. D., Brewer, H. B., & Santamarina-Fojo, S. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32375-0 · Cited by 54
Self-citationLocus heterogeneity in progressive familial intrahepatic cholestasis.
Strautnieks, S. S., Kagalwalla, A. F., Tanner, M. S., Gardiner, R. M., & Thompson, R. J. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.10.833 · Cited by 40
THE MECHANISM OF BILIARY LIPID SECRETION AND ITS DEFECTS
Elferink, R. P. J. O., & Groen, A. K. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70043-1 · Cited by 27
Barbiturates and Biliary Function
Capron, J. P., & Erlinger, S. (2009) · Digestion · doi:10.1159/000197653 · Cited by 20
Becker, M., von Bergmann, K., Rotthauwe, H. W., & Leiß, O. (1984) · European Journal of Pediatrics · doi:10.1007/bf00442746 · Cited by 10
BILE ACID ABNORMALITIES IN CHOLESTATIC LIVER DISEASES
Salen, G., & BATTA, A. K. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70049-2 · Cited by 9
Research works printed but not linked: 2
- Hofmann, 1995, Ital. J. Gastroenterol., 27, 106
- Seol, 1995, Mol. Endocrinol., 9, 72
Cited by
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Lefebvre, P., Cariou, B., Lien, F., Kuipers, F., & Staels, B. (2009) · Physiological Reviews · doi:10.1152/physrev.00010.2008 · Cited by 1,678
“These properties, underlining the concerted action of VDR, FXR, PXR, and CAR in protecting against BA toxicity in the liver and intestinal tract (97, 262), may be confounding when analyzing structure-activity relationships.”
BackgroundBile Acid Metabolism and Signaling
Chiang, J. Y. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00517.x · Cited by 279
“FXR, PXR and constitutive androstane receptor (CAR) may play a complementary role in detoxification of bile acids and protection against cholestasis (76).”
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
“…conditions results in repression of bile acid synthesis and increases bile acid detoxification and excretion and may therefore protect hepatocytes from bile acid toxicity (Guo et al. 2003; Han and Chiang 2009; Maglich et al. 2002; Staudinger et al. 2001; Xie et al. 2001; Wang et al. 2002).”
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935
“A number of studies showed that activation of CAR was beneficial for protecting against bile acid toxicity during cholestasis in mice (Guo et al., 2003; Saini et al., 2004; Stedman et al., 2005; Beilke et al., 2009).”
BackgroundApoptosis and Necrosis in the Liver: A Tale of Two Deaths?
Malhi, H., Gores, G. J., & Lemasters, J. J. (2006) · Hepatology · doi:10.1002/hep.21062 · Cited by 691
Metadata
- Authors
- Guo, G. L., Lambert, G., Negishi, M., Ward, J. M., Brewer, H. B., Kliewer, S. A., Gonzalez, F. J., & Sinal, C. J.
- Affiliations
- National Institutes of Health (US)
- Inserm (FR)
- National Cancer Institute (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Gonzalez, Frank J.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 278
- Issue
- 46
- Pages
- 45062-45071
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2168485100
- Cited by
- 312
- References
- 37
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 7 · 2023: 10 · 2022: 7 · 2021: 8 · 2020: 10 · 2019: 9 · 2018: 9 · 2017: 10 · 2016: 6 · 2015: 6 · 2014: 9 · 2013: 20 · 2012: 13
- FWCI
- 11.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6175 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- farnesoid X receptor, pregnane X receptor, constitutive androstane receptor, bile acid toxicity, cholic acid, bile acid homeostasis, cholesterol homeostasis, lipid homeostasis, cholestasis, bilirubin metabolism, phenobarbital, TCPOBOP, CYP2B, CYP3A, MRP2, MRP3, UGT1A, alpha-glutathione S-transferase
- MeSH terms
- Pregnane X Receptor, Constitutive Androstane Receptor, Receptor, Farnesoid X-Activated, Animals, Animal Feed, Aryl Hydrocarbon Hydroxylases, Bile Acids and Salts, Bilirubin, Biological Transport, Body Weight, Cell Nucleus, Cholesterol, Cloning, Molecular, Crosses, Genetic, DNA-Binding Proteins, Glutathione Transferase, Liver, Mice, Transgenic, Oxidoreductases, N-Demethylating, Phenobarbital, Phospholipids, Pyridines, Receptors, Steroid, Ribosomal Proteins, Time Factors, Transcription Factors, Blotting, Northern, Up-Regulation, Gene Deletion, Receptors, Cytoplasmic and Nuclear, Mitochondrial Proteins, Saccharomyces cerevisiae Proteins, Lipid Metabolism, Mice, Cytochrome P-450 CYP3A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.